Streetbeat News

Regulatory

ADBE

BKE

BW

ISRG

JBL

U.S. stock futures traded lower on Friday, with focus on companies like Jabil Inc., Adobe Inc, The Buckle, Inc., Babcock & Wilcox Enterprises, Inc., and Intuitive Surgical, Inc. Jabil is expected to report earnings, Adobe issued weak revenue guidance, Buckle's earnings are anticipated, Babcock & Wilcox reported disappointing results, and Intuitive Surgical gained after FDA clearance for da Vinci 5.

Portfolio Pulse from Avi Kapoor

March 15, 2024 | 8:15 am

META

Elon Musk criticizes the proposed TikTok bill, H.R. 7521, which aims to ban foreign adversary controlled applications in the U.S., including TikTok. Musk warns the bill is too broad and could be misused. The bill's approval by the U.S. House of Representatives has sparked debate and speculation about a potential sale of TikTok. The controversy has positively impacted the stock prices of rival social media companies, notably Meta Platforms Inc (NASDAQ:META).

Portfolio Pulse from Benzinga Neuro

March 15, 2024 | 7:21 am

DJCO

Daily Journal Corporation (DJCO) received a Nasdaq non-compliance notice due to an audit committee requirement issue. The company has until November 28, 2024, or its next annual shareholders' meeting, whichever is earlier, to regain compliance. DJCO plans to address this by filling the board and audit committee vacancy with a qualified individual in advance of the deadline.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 6:35 am

MOVE

Movano Health's Evie Ring, a consumer wellness device, has exceeded FDA accuracy guidelines in its second hypoxia trial, achieving a root mean square error average of 2.46% against the FDA guidance of 3.5% for SpO2. The trial used the commercial production model of the Evie Ring, which will be submitted to the FDA and sold under the brand name Evie Med. The device outperformed two hospital-grade reference pulse oximeters in the study.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 6:28 am

BTCUSD

Bitcoin (BTC) experienced an 8% drop to below $67K, attributed to concerns over persistent inflation and speculation about the Federal Reserve maintaining higher interest rates. The cryptocurrency community remains optimistic, with some seeing the dip as a buying opportunity.

Portfolio Pulse from Mehab Qureshi

March 15, 2024 | 6:19 am

BMY

Bristol Myers Squibb's Breyanzi has been approved by the U.S. FDA as the first and only CAR T cell therapy for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This approval marks a significant advancement in treatment options for patients with these conditions, offering a one-time infusion that has shown deep and durable responses. In the TRANSCEND CLL 004 trial, 20% of patients achieved a complete response, with the median duration of response not yet reached. Breyanzi is also approved for relapsed or refractory large B-cell lymphoma, expanding its potential patient base.

Portfolio Pulse from Benzinga Newsdesk

March 15, 2024 | 5:28 am

BTCUSD

A new poll by Paradigm shows that 48% of U.S. voters with cryptocurrency holdings prefer Donald Trump for the 2024 elections, over Joe Biden who has 39% support. The survey, conducted by Public Opinion Strategies, indicates a tight race with a 3.5% margin of error. It also highlights a general distrust in both political parties' crypto policies. Additionally, the poll suggests a growing interest in Bitcoin and Bitcoin ETFs among voters.

Portfolio Pulse from Mehab Qureshi

March 15, 2024 | 5:11 am

BTCUSD

El Salvador has transferred $400 million worth of Bitcoin to a cold wallet for enhanced security, as announced by President Nayib Bukele. This move increases the country's disclosed Bitcoin holdings significantly, revealing an investment larger than previously estimated. The transfer aims to safeguard the nation's cryptocurrency assets by utilizing a cold wallet, a secure offline storage method. This strategic decision reflects El Salvador's broader commitment to integrating Bitcoin into its treasury, marking a significant milestone since its initial investment in September 2021.

Portfolio Pulse from Mehab Qureshi

March 15, 2024 | 4:49 am

SSNLF

TSM

The U.S. government is reportedly set to provide over $6 billion to Samsung Electronics (OTC:SSNLF) to expand its chip production in the U.S., as part of the 2022 Chips and Science Act. This move aims to boost domestic chip production amid a global shortage and reduce dependence on foreign manufacturers. Additionally, Taiwan Semiconductor Manufacturing Co. (NYSE:TSM) is also expected to receive over $5 billion in funding, highlighting the U.S. government's commitment to fostering competition in the chipmaking industry.

Portfolio Pulse from Benzinga Neuro

March 15, 2024 | 1:43 am

AQST

Aquestive Therapeutics announced that Anaphylm has met all predefined primary and secondary pharmacokinetic endpoints and reaffirmed its goal of filing a New Drug Application (NDA) before the end of 2024. The company also successfully completed a Type C meeting with the FDA, addressing previous concerns by modifying administration instructions and providing additional information for its NDA submission.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 9:26 pm